Integrating spatial analysis in mixed methods approach to improve MDA Access by reaching underserved and vulnerable populations of Mali in NTD elimination framework

This mixed methods study plans to focus activities around two kinds of mobile, underserved populations: nomadic pastoralists in the rural district of Tominian and economic migrants and displaced groups from conflict areas in the urban district of Kalabancoro. Activities include:

  1. Quantitative questionnaire with a micro-narrative component. Micro-narratives are an established methodology focused on rapidly collecting qualitative data from a large number of participants
  2. Spatial analysis of study participants
  3. In-depth interviews and focus group discussions with health workers and community/opinion leaders
  4. Integrated analysis of the spatial data with questionnaire and micro-narrative data to better describe trends in the targeted vulnerable populations with respect to accessibility and acceptability of NTD program services

The team aims to combine spatial analysis with qualitative data collection to answer the following research questions:

  1. What are the factors leading to low coverage of MDA within underserved and vulnerable populations in Malian community?
  2. How are underserved and vulnerable populations currently being served by the public health interventions/health system?
  3. How effective and efficient is the ISAMA process for NTDs coverage in underserved and vulnerable populations compared to the current data collection and analysis approach?
  4. What critical factors influence the use of ISAMA approach in data analysis system process?
  5. How are characteristics of low coverage geographically distributed and the factors associated in underserved and vulnerable populations?
  6. Who are the underserved populations and what are their characteristics?
Countries: Mali

Lead on social science

Determine the best health systems approaches for:

1. Improved planning and delivery of integrated programmes; 
2. Increased and sustained access to NTD drugs; 
3. Harmonised inter-sectoral approach; and 
4. Strong and generalisable evidence base for integrated elimination and control of NTDs.